Vitexin
CAS No. 3681-93-4
Vitexin( Vitexin, Apigenin 8-C-glucoside )
Catalog No. M18481 CAS No. 3681-93-4
Vitexin protects brain against cerebral I/R injury, and this effect may be regulated by mitogen-activated protein kinase (MAPK) and apoptosis signaling pathways.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 42 | In Stock |
|
10MG | 72 | In Stock |
|
25MG | 138 | In Stock |
|
50MG | 223 | In Stock |
|
100MG | 332 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameVitexin
-
NoteResearch use only, not for human use.
-
Brief DescriptionVitexin protects brain against cerebral I/R injury, and this effect may be regulated by mitogen-activated protein kinase (MAPK) and apoptosis signaling pathways.
-
DescriptionVitexin has antinociceptive and antispasmodic activities.Vitexin exhibits a prominent first-pass effect. Vitexin has antioxidant, antimyeloperoxidase, and α-glucosidase inhibitory activities. Vitexin can either inhibit or induce activities of CYP2C11 and CYP3A1. Vitexin induces the novel p53-dependent metastatic and apoptotic pathway. Vitexin protects brain against cerebral I/R injury, and this effect may be regulated by mitogen-activated protein kinase (MAPK) and apoptosis signaling pathways.
-
In Vitro——
-
In Vivo——
-
SynonymsVitexin, Apigenin 8-C-glucoside
-
PathwayMembrane Transporter/Ion Channel
-
TargetTRP/TRPV Channel
-
RecptorAntioxidant
-
Research AreaOthers-Field
-
Indication——
Chemical Information
-
CAS Number3681-93-4
-
Formula Weight432.38
-
Molecular FormulaC21H20O10
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 62.5 mg/mL (144.55 mM)
-
SMILESC1=CC(=CC=C1C2=CC(=O)C3=C(O2)C(=C(C=C3O)O)C4C(C(C(C(O4)CO)O)O)O)O
-
Chemical Name4H-1-Benzopyran-4-one, 5,7-dihydroxy-8-beta-D-glucopyranosyl-2-(4-hydroxyphenyl)-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
HhAntag
HhAntag is a small molecule inhibitor of GLI1-mediated transcription, an essential down-stream element of the Hedgehog (Hh) pathway with the anti-tumor activity.
-
SB-705498
A potent, selective and orally bioavailable TRPV1 antagonist with pKi of 7.6 (inhibition of capsaicin-mediated activation of hTRPV1 receptor).
-
RN-1734
RN-1734 is selective TRPV4 channel antagonist(IC50 of 2.3 μM5.9 μM3.2 μM for hTRPV4 ?mTRPV4 and rTRPV4respectively).